for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Lantheus Holdings Inc

LNTH.OQ

Latest Trade

26.38USD

Change

0.54(+2.09%)

Volume

286,679

Today's Range

25.52

 - 

26.55

52 Week Range

12.60

 - 

29.80

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
25.84
Open
25.81
Volume
286,679
3M AVG Volume
7.99
Today's High
26.55
Today's Low
25.52
52 Week High
29.80
52 Week Low
12.60
Shares Out (MIL)
39.08
Market Cap (MIL)
1,030.92
Forward P/E
23.42
Dividend (Yield %)
--

Next Event

Q4 2019 Lantheus Holdings Inc Earnings Release

Latest Developments

More

Lantheus Holdings Q2 Adjusted Earnings Per Share $0.27

Lantheus Holdings' Unit Refinanced Its Existing Indebtedness With New Term Loan Facility

Lantheus Announces Strategic Collaboration With Nanomab

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Lantheus Holdings Inc

Lantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.

Industry

Medical Equipment & Supplies

Contact Info

331 Treble Cove Rd

+1.978.6718001

http://www.lantheus.com/

Executive Leadership

Brian A. Markison

Non-Executive Independent Chairman of the board

Mary Anne Heino

President, Chief Executive Officer, Director

Robert J. Marshall

Chief Financial Officer, Treasurer

John Bolla

Chief Operating Officer, Senior Vice President, Technical Operations

Michael P. Duffy

Senior Vice President, Law and Public Policy, General Counsel and Secretary

Key Stats

1.75 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.3K

2017

0.3K

2018

0.3K

2019(E)

0.3K
EPS (USD)

2016

0.720

2017

1.000

2018

0.940

2019(E)

1.103
Price To Earnings (TTM)
26.91
Price To Sales (TTM)
2.97
Price To Book (MRQ)
11.17
Price To Cash Flow (TTM)
19.70
Total Debt To Equity (MRQ)
215.55
LT Debt To Equity (MRQ)
204.57
Return on Investment (TTM)
11.19
Return on Equity (TTM)
9.83

Latest News

BRIEF-Lantheus Holdings Q1 Earnings Per Share $0.21

* Q1 EARNINGS PER SHARE VIEW $0.22 -- THOMSON REUTERS I/B/E/S

BRIEF-Lantheus Holdings Appoints Gary Pruden, Kenneth Pucel And Dr. James Thrall To Board Of Directors

* LANTHEUS HOLDINGS APPOINTS GARY PRUDEN, KENNETH PUCEL AND DR. JAMES THRALL TO ITS BOARD OF DIRECTORS

BRIEF-Lantheus Holdings Reports Q4 Earnings Per Share $2.47

* LANTHEUS HOLDINGS, INC. REPORTS 2017 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS; PROVIDES 2018 GUIDANCE

BRIEF-Lantheus Holdings Says Lantheus Medical Entered Extension Of Supply Agreement With Jubilant Drax Images​

* LANTHEUS HOLDINGS-ON DEC. 30, 2017, LANTHEUS MEDICAL ENTERED BINDING EXTENSION OF SUPPLY AGREEMENT WITH JUBILANT DRAX IMAGES,EFFECTIVE JAN. 1, 2018

BRIEF-Lantheus Holdings reports Q3 earnings per share $0.22

* Lantheus Holdings Inc reports 2017 third quarter financial results; exceeds third quarter and raises full-year 2017 guidance

BRIEF-Lantheus Holdings Q2 earnings per share $0.35

* Lantheus Holdings, Inc. reports 2017 second quarter financial results; exceeds second quarter and raises full-year 2017 guidance

BRIEF-Lantheus Holdings sees Q2 revenue $79 mln-$82 mln

* Lantheus Holdings, Inc. Reports 2017 first quarter financial results; exceeds first quarter and raises full-year 2017 guidance

BRIEF-Lantheus announces refinancing of its debt facility

* Lantheus Holdings Inc says closing of a new $275 million term loan facility and a new $75 million five-year cash-flow revolver facility

BRIEF-Lantheus Holdings reports Q4 EPS $0.13

* Reports 2016 fourth quarter and full year financial results; provides 2017 guidance

BRIEF-Lantheus Holdings appoints new member to its board of directors

* Lantheus Holdings appoints new member to its board of directors

BRIEF-Lantheus Holdings says upsized public offering to 3.5 mln shares

* Says intends to increase amount of shares offered for sale by 500,000 shares

BRIEF-Lantheus Holdings announces public offering of 3 mln shares of common stock

* Lantheus Holdings-intends to use net proceeds, with cash on hand,to repay about $20 million of outstanding principal balance under senior credit facilities

BRIEF-Lantheus holdings forecast revenue $296 mln to $299 mln

* FY 2016 revenue view $293.7 million -- Thomson Reuters I/B/E/S

BRIEF-Lantheus Holdings announces public offering of 5,200,000 shares of common stock

* Lantheus holdings, inc. Announces public offering of 5,200,000 shares of common stock

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up